Anne Lesage, PhD

Anne Lesage, PhD

SVP Preclinical Development

Dr. Lesage is a co-founder of Pharvaris and has led the preclinical development since its inception. Anne has over 25 years’ experience in the pharmaceutical industry, including drug discovery, preclinical development, early clinical development and scientific, operational and strategic consulting. Anne is a senior expert in program management, due diligence, risk assessment, gap analysis, and designing and leading cost-effective strategies towards exits.
In 2010, Anne founded GrayMatters Consulting, and has been working with small and midsize biotech since then, consulting and engaging in interim positions to develop and leverage assets towards valorization. In 1992, she joined the neuroscience drug discovery unit at Janssen Pharmaceutica (Johnson & Johnson), where she held different leadership positions with increasing responsibility. Anne is inventor on 9 patents and author on 45 publications. Anne is trained as biochemist and holds a Ph.D. in molecular biology.
Anne was a post-doctoral fellow in the Child Psychiatry department of Stanford University Medical School and in the CNRS Laboratory of Viral Oncology of Hospital Paul Brousse in Paris. She holds a middle management MBA from the Vlerick Business School. She is also co-founder of Kosa Pharma.